APA (7th ed.) Citation

Mata, D. A., Lee, J. K., Shanmugam, V., Marcus, C. B., Schrock, A. B., Williams, E. A., . . . Xu, M. L. (2024). Liquid biopsy‐based circulating tumour (ct)DNA analysis of a spectrum of myeloid and lymphoid malignancies yields clinically actionable results. Histopathology, 84(7), 1224. https://doi.org/10.1111/his.15168

Chicago Style (17th ed.) Citation

Mata, Douglas A., et al. "Liquid Biopsy‐based Circulating Tumour (ct)DNA Analysis of a Spectrum of Myeloid and Lymphoid Malignancies Yields Clinically Actionable Results." Histopathology 84, no. 7 (2024): 1224. https://doi.org/10.1111/his.15168.

MLA (9th ed.) Citation

Mata, Douglas A., et al. "Liquid Biopsy‐based Circulating Tumour (ct)DNA Analysis of a Spectrum of Myeloid and Lymphoid Malignancies Yields Clinically Actionable Results." Histopathology, vol. 84, no. 7, 2024, p. 1224, https://doi.org/10.1111/his.15168.